Dr Navid Malik, analyst at The Life Sciences Division talks to Directors Talk about the opportunities for Lupuzor™ – Sept 2019

13th September 2019 - 3:18 pm

ImmuPharma plc (LON: IMM) is the topic of conversation when Navid Malik Executive Director at The Life Sciences Division joins DirectorsTalk. Navid provides some background to TLSD and it’s interest in ImmuPharma, gives a summary of it’s new note on the company, provides some key points on the longer term potential of Lupuzor.

Share this article